SCHEMBL8974451

SCHEMBL8974451

CS(=O)(=O)c1ccc(C2=CC(CF)C=C2c2ccc(F)cc2)cn1

nearest known ligand 0.37

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CDK9 P50750 1/20 0.37
PTGS2 P35354 14/20 0.36
PIK3CD O00329 1/20 0.36
PIP5K1C O60331 1/20 0.36
PIK3CB P42338 1/20 0.36
PI4KA P42356 1/20 0.36
PIK3CG P48736 1/20 0.36
PI4KB Q9UBF8 1/20 0.36
PTGS1 P23219 3/20 0.35
HTR2A P28223 2/20 0.35
KCNH2 Q12809 2/20 0.35
RORC P51449 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8974112 0.90 CDK9 (0.37) CDK9PTGS2PIK3CDPIP5K1CPIK3CB
SCHEMBL8974563 0.88 PTGS2 (0.37) CDK9PTGS2PIK3CDPIP5K1CPIK3CB
SCHEMBL8974667 0.87 CA1 (0.40) PTGS2PTGS1HTR2AKCNH2
SCHEMBL8974776 0.86 PPARD (0.36) PTGS2PIK3CDPIP5K1CPIK3CBPI4KA
SCHEMBL8973732 0.85 PTGS2 (0.40) CDK9PTGS2PIK3CDPIP5K1CPIK3CB
SCHEMBL8974127 0.82 KDM4E (0.36) CDK9PTGS2PIK3CDPIP5K1CPIK3CB
SCHEMBL8973860 0.81 PTGS2 (0.35) CDK9PTGS2PIK3CDPIP5K1CPIK3CB
SCHEMBL8973777 0.80 PTGS2 (0.54) PTGS2PTGS1
SCHEMBL8974070 0.79 PTGS2 (0.44) CDK9PTGS2PIK3CDPIP5K1CPIK3CB
SCHEMBL8974732 0.79 PTGS2 (0.41) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5576339-A Pyridyl substituted cyclopentadienes for the treatment of inflamation HUANG HORNG-CHIH (US) 1996-11-19 US disclosed
WO-1995030656-A1 SUBSTITUTED CYCLOPENTADIENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO disclosed
US-5418254-A Side effect reduction G. D. SEARLE & CO. (US) 1995-05-23 US disclosed